Adrenomedullin alleviates collagen accumulation in pulmonary arteries of rats with hypoxic pulmonary hypertenison

Chinese Journal of Contemporary Pediatrics

Volumn 14, Issue 1, 2012, Pages 54-58

  Qi, Jian Guang ^a   Xing, Chang Qing ^a   Ding, Ya Guang ^a   Du, Jun Bao ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Adrenomedullin; Collagen; Hypoxia; Pulmonary hypertension; Rats

Indexed keywords

ADRENOMEDULLIN; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLLAGEN METABOLISM; CONTROLLED STUDY; HYPOXIA; IMMUNOHISTOCHEMISTRY; LUNG ARTERY PRESSURE; MALE; NONHUMAN; PROTEIN EXPRESSION; PULMONARY ARTERY; PULMONARY HYPERTENSION; RAT;

ADRENOMEDULLIN; ANIMALS; ANOXIA; COLLAGEN; HYPERTENSION, PULMONARY; MALE; PULMONARY ARTERY; RATS; RATS, WISTAR; TRANSFORMING GROWTH FACTOR BETA;

EID: 84856368228     PISSN: 10088830     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Ooi CY, Wang Z, Tabima DM, Eickhoff JC, Chesler NC. The role of collagen in extralobar pulmonary artery stiffening in response to hypoxia-induced pulmonary hypertension[J]. Am J Physiol Heart Circ Physiol, 2010, 299(6): H1823-H1831.
2. Qi JG, Ding YG, Tang CS, Du JB. Chronic administration of adrenomedullin attenuates hypoxic pulmonary vascular structural remodeling and inhibits proadrenomedullin N-terminal 20-peptide production in rats[J]. Peptides, 2007, 28(4): 910-919.
3. Murakami S, Kimura H, Kangawa K, Nagaya N. Physiological significance and therapeutic potential of adrenomedullin in pulmonary hypertension[J]. Cardiovasc Hematol Disord Drug Targets, 2006, 6(2): 125-132.
4. Matsui H, Shimosawa T, Itakura K, Xing GQ, Ando K, Fujita T. Adrenomedullin can protect against pulmonary vascular remodeling induced by hypoxia[J]. Circulation, 2004, 109(18): 2246-2251. (Pubitemid 38625404)
5. Ishimitsu T, Ono H, Minami J, Matsuoka H. Pathophysiologic and therapeutic implications of adrenomedullin in cardiovascular disorders[J]. Phamacol Ther, 2006, 111(3): 909-927. (Pubitemid 44118439)
6. Nakanishi K, Osada H, Uenoyama M, Kanazawa F, Ohrui N, Masaki Y, et al. Expression of adrenomedullin mRNA and protein in rats with hypobaric hypoxia-induced pulmonary hypertension[J]. Am J Physiol Heart Physiol, 2004, 286(6): H2159-H2168. (Pubitemid 38685230)
7. Bobik A. Transforming growth factor-betas and vascular disorders[J]. Arterioscler Thromb Vasc Biol, 2006, 26(8): 1712-1720. (Pubitemid 44305323)
8. Eickelberg O, Köhler E, Reichenberger F, Bertschin S, Woodtli T, Erne P, et al. Extracellular matrix deposition by primary human lung fibroblasts in response to TGF-beta1 and TGF-beta3[J]. Am J Physiol, 1999, 276(5 Pt 1): L814-L824. (Pubitemid 29249635)
9. Long L, Crosby A, Yang X, Southwood M, Upton PD, Kim DK, et al. Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension: potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease[J]. Circulation, 2009, 119(4): 566-576.